Quality-of-Life Analysis Published From ATTRACT Trial of Pharmacomechanical Catheter-Directed Thrombolysis of Proximal DVT
December 19, 2019—The Society for Vascular Surgery (SVS) announced that the findings from a quality-of-life (QOL) analysis of data from the ATTRACT trial were published by Susan R. Kahn, MD, et al in Journal of Vascular Surgery: Venous and Lymphatic Disorders (2019;8:8–23.e18).
AVLS Advises That CMS Will Require Mandatory Prior Authorization for Vein Ablation in Hospital Outpatient Setting
December 18, 2019—The American Vein and Lymphatic Society (AVLS) advised its members who practice in the hospital outpatient setting (“Place of Service 22”) that in the 2020 Medicare Hospital Outpatient Final Rule issued in November, the Centers for Medicare & Medicaid Services (CMS) affirmed that effective July 1, 2020, vein ablation will require (in almost all cases) prior authorization in the formal Hospital Outpatient Prospective Payment System setting.
AVLS Issues Recommendations on Ultrasound Testing for Venous Insufficiency of Lower Extremities
December 10, 2019—The American Vein & Lymphatic Society (AVLS) issued a statement on behalf of the AVLS Ultrasound Section advising that all testing for venous insufficiency of the lower extremities should be done in the standing position, unless constrained by physical limitations of the patient.
American Venous Forum to Collaborate With NIH's C-TRACT Trial
November 14, 2019—In a letter to American Venous Forum (AVF) members, AVF President Brajesh K. Lal, MD, announced that the AVF and the National Institutes of Health–funded C-TRACT trial have entered into a partnership in which the AVF will contribute its expertise, perspective, and work effort to advance the trial’s success.
European Societies Publish Consensus Document on Follow-Up After Revascularization for PAD
November 14, 2019—A consensus document from European societies on the follow-up of patients after revascularization for peripheral artery disease (PAD) was published by Maarit Venermo, MD, et al in the European Journal of Vascular and Endovascular Surgery (2019;58:641–653).
Early Outcomes Presented for Inari's ClotTriever System to Treat DVT
November 6, 2019—Inari Medical, Inc. announced the presentation of early outcomes from CLOUT, the ClotTriever Outcomes Registry evaluating the company’s ClotTriever mechanical thrombectomy system for treatment of acute and chronic lower extremity deep vein thrombosis (DVT).
Treatment of Lateral Subdermic Plexus Insufficiency Evaluated for Restless Leg Syndrome
November 6, 2019—VIVA Physicians announced that Swar Shah, MD, presented findings from an investigation of the etiologies of restless leg syndrome (RLS) and nighttime leg cramping in a late-breaking clinical trial session at VIVA 2019, the Vascular InterVentional Advances meeting held November 4–7 in Las Vegas, Nevada.
IVUS Shows Superiority to Venography in Identifying Treatment Zones for Iliac Vein Stenting
October 30, 2019—The Society for Vascular Surgery (SVS) announced the publication of an evaluation of a large series of iliac vein stent cases in a blinded comparison that found intravascular ultrasound (IVUS) superior to venography in determining the proper location of treatment zones.
FDA Clears Sky Medical Technology's Geko Calf-Stimulation Device for VTE Prevention
October 22, 2019—Sky Medical Technology Ltd, a United Kingdom–based medical devices company, announced FDA 510(k) clearance for its Geko device for stimulation of the calf muscles to prevent venous thrombosis in nonsurgical patients at risk for venous thromboembolism (VTE).
Venarum Medical Receives Ongoing NIH SBIR Grant Support for its EndoVenous Valve System
October 21, 2019—Venarum Medical, LLC announced receipt of a mentorship grant in further support of its awarded National Institutes of Health (NIH) Small Business Innovation Research (SBIR) phase 2 grant for the company’s EndoVenous valve system (EVVS), which is currently underway.
Financing Will Support Launch of Access Vascular's HydroPICC
September 26, 2019—Access Vascular announced $6 million in new funding from new and existing investors to support the launch of its next-generation FDA-cleared HydroPICC peripherally inserted central catheter, as well as the initiation of the company's first postmarket registry study.
Clinical Results Published for Bluegrass Vascular's Surfacer System
September 24, 2019—Bluegrass Vascular Technologies announced that results associated with the clinical use of the company’s Surfacer Inside-Out access catheter system were published by Dirk M. Hentschel, MD, et al in The Journal of Vascular Access (JVA).
FDA Grants Breakthrough Device Designation for Concept Medical's MagicTouch AVF Sirolimus-Coated Balloon
August 29, 2019—Concept Medical Inc. announced that it has been granted FDA Breakthrough Device designation for the company's MagicTouch arteriovenous fistula (AVF) sirolimus-coated balloon (SCB) catheter for the treatment of stenotic lesions of AVFs or AV grafts (AVGs) in hemodialysis treatment of renal failure.
Predictions for Transradial Access Capabilities in the Near Future
A discussion of available technology for transradial access in patients with aortoiliac and infrainguinal disease, current limitations, and opportunities for the future.
By Young Joon (Fred) Kwon, MSE; Raghuram Posham, MD, MPA; Rahul S. Patel, MD, FSIR; and Aaron Fischman, MD, FSIR, FCIRSE
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.